Literature DB >> 9796860

Depression subtyping: treatment implications.

P J Clayton1.   

Abstract

The complexity of subtyping depression and the implications that such subtyping has on treatment choices are discussed in this article. The most recent edition of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) directs clinicians to classify the mood disorders in depressed patients as unipolar, bipolar, due to a general medical condition, or due to substance abuse. The focus of this article is unipolar (major depression and dysthymia) and bipolar I and II disorders with and without feature specifiers for atypical depression, seasonal affective disorder, psychotic depression, and postpartum depression. Anxious depression, which is not a DSM-IV classification, is also reviewed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796860

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  The role of monoamine oxidase inhibitors in current psychiatric practice.

Authors:  Jess G Fiedorowicz; Karen L Swartz
Journal:  J Psychiatr Pract       Date:  2004-07       Impact factor: 1.325

Review 2.  Evaluation of newer treatment interventions for psychotic depression.

Authors:  B L O'Neal; C L Smith; M Trivedi
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

3.  Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphé tryptophan hydroxylase gene expression.

Authors:  Willem Heydendael; Lauren Jacobson
Journal:  Brain Res       Date:  2009-07-03       Impact factor: 3.252

4.  Anxious-depression among Hispanic/Latinos from different backgrounds: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Álvaro Camacho; Patricia Gonzalez; Christina Buelna; Kristen T Emory; Gregory A Talavera; Sheila F Castañeda; Rebeca A Espinoza; Annie G Howard; Krista M Perreira; Carmen R Isasi; Martha L Daviglus; Scott C Roesch
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-09-12       Impact factor: 4.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.